Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8835377 | 0.84 | — | — | |
| SCHEMBL8834800 | 0.81 | TSHR (0.38) | TSHRMAPTABCC4ALDH1A1 | |
| SCHEMBL8834569 | 0.77 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL14716699 | 0.76 | TSHR (0.50) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL1710316 | 0.76 | TSHR (0.43) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL7526836 | 0.76 | TSHR (0.50) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL5440190 | 0.75 | — | — | |
| SCHEMBL3674102 | 0.75 | TSHR (0.36) | TSHRMAPTABCC4ALDH1A1 | |
| SCHEMBL30487039 | 0.73 | TSHR (0.37) | TSHRMAPTABCC4ALDH1A1USP2 | |
| SCHEMBL22791487 | 0.72 | TSHR (0.46) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5686021-A | Liquid crystal display device, methods of producing and driving the liquid crystal display device, and liquid crystal composition | IDEMITSU KOSAN CO., LTD. (JP) | 1997-11-11 | — | — | US | disclosed |